Roivant Sciences Ltd. is 10% Owner at Urovant Sciences Ltd. (UROV). They have made 21 open-market trades across 5 companies since 2017, most recently 2025-12-12.
CIK 0001635088
21 open-market purchases totalling $982.5M since 2017, never a sale. Across 21 scored buys the stock is down 7.5% at ninety days, and 8.3 points behind the S&P over the same stretch.
21 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 48% | 38% | 38% |
| Avg Move | -0.5% | -2.4% | -7.5% |
| Alpha | -1.3% | -4.6% | -8.3% |
| Scored | 21 | 21 | 21 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | BUY | 2025-12-12 | 2025-12-12 | $21.00 | $350.0M | +0.6% | -3.4% | -6.5% |
| IMVT | BUY | 2025-01-13 | 2025-01-15 | $20.00 | $336.9M | -11.5% | -18.3% | -37.8% |
| IMVT | BUY | 2023-10-02 | 2023-10-04 | $38.00 | $58.0M | +8.2% | -2.6% | +18.6% |
| IMVT | BUY | 2022-10-06 | 2022-10-07 | $6.00 | $2.5M | -0.6% | +36.2% | +101.6% |
| IMVT | BUY | 2020-09-04 | 2020-09-04 | $33.00 | $12.5M | +5.9% | +6.3% | +38.6% |
| IMVT | BUY | 2020-04-16 | 2020-04-17 | $14.50 | $30.0M | +1.3% | +1.9% | +29.8% |
| AXGT | BUY | 2020-02-24 | 2020-02-27 | $3.75 | $40.0M | -12.7% | -27.2% | +5.6% |
| MYOV | BUY | 2019-12-16 | 2019-12-18 | $15.38 | $3.8M | -3.2% | -13.4% | -52.7% |
| MYOV | BUY | 2019-12-16 | 2019-12-18 | $15.13 | $2.6M | -3.2% | -13.4% | -52.7% |
| MYOV | BUY | 2019-12-04 | 2019-12-04 | $17.04 | $1.2M | -11.7% | -19.5% | -42.0% |
| MYOV | BUY | 2019-12-02 | 2019-12-04 | $18.44 | $3.3M | -11.7% | -19.5% | -42.0% |
| MYOV | BUY | 2019-12-02 | 2019-12-04 | $18.03 | $4.6M | -11.7% | -19.5% | -42.0% |
| MYOV | BUY | 2019-11-25 | 2019-11-27 | $15.00 | $52.5M | -12.0% | -14.1% | -44.1% |
| MYOV | BUY | 2019-11-21 | 2019-11-22 | $11.89 | $1.4M | +15.1% | +17.0% | -23.4% |
| MYOV | BUY | 2019-11-20 | 2019-11-22 | $12.90 | $1.6M | +15.1% | +17.0% | -23.4% |
| MYOV | BUY | 2019-11-20 | 2019-11-22 | $12.39 | $3.0M | +15.1% | +17.0% | -23.4% |
| UROV | BUY | 2019-06-17 | 2019-06-19 | $8.31 | $151K | -5.1% | +3.9% | +15.5% |
| UROV | BUY | 2019-06-12 | 2019-06-14 | $8.06 | $177K | -2.4% | +19.6% | +18.9% |
| UROV | BUY | 2019-06-07 | 2019-06-11 | $8.29 | $115K | -6.7% | +6.1% | +20.7% |
| UROV | BUY | 2019-06-05 | 2019-06-06 | $8.02 | $52K | +4.5% | +2.1% | +13.9% |
| MYOV | BUY | 2019-06-04 | 2019-06-06 | $8.25 | $20.0M | -2.7% | -12.4% | -14.1% |
| UROV | BUY | 2019-05-30 | 2019-06-03 | $7.83 | $139K | +0.0% | +2.4% | +19.1% |
| UROV | BUY | 2019-05-24 | 2019-05-29 | $7.62 | $110K | +7.2% | -0.4% | -4.7% |
| UROV | BUY | 2019-05-21 | 2019-05-23 | $8.22 | $163K | +3.6% | +4.3% | +1.6% |
| UROV | BUY | 2019-05-16 | 2019-05-20 | $7.54 | $163K | -6.8% | -0.8% | -4.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.